Free Trial

NeuroOne Medical Technologies (NMTC) SEC Filings & 10K Form

NeuroOne Medical Technologies logo
$0.76 +0.00 (+0.03%)
(As of 12/20/2024 05:31 PM ET)

Recent NeuroOne Medical Technologies SEC Filings

DateFilerForm TypeView
12/17/2024
7:40 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
7:29 AM
NeuroOne Medical Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/03/2024
3:50 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:57 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:04 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:42 AM
LYTTON LAURENCE W (Filed by)
NeuroOne Medical Technologies (Subject)
Form SC 13G/A
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
NeuroOne Medical Technologies (Subject)
Form SCHEDULE 13G/A
11/01/2024
4:06 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:14 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:23 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:05 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
10:32 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
10:44 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
10:22 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2024
11:15 PM
NeuroOne Medical Technologies (Filer)
Form EFFECT
09/13/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
8:03 AM
NeuroOne Medical Technologies (Filer)
Form S-3/A
09/04/2024
10:36 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
10:43 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
10:26 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2024
11:15 PM
NeuroOne Medical Technologies (Filer)
Form EFFECT
08/16/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 424B5
08/16/2024
9:39 AM
NeuroOne Medical Technologies (Filer)
Form D
Notice of Exempt Offering of Securities 
08/14/2024
3:34 PM
NeuroOne Medical Technologies (Filer)
Form S-3/A
08/14/2024
7:59 AM
NeuroOne Medical Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
1:31 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
1:38 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
1:16 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:49 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
10:00 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
10:09 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
10:21 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:15 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
2:34 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:49 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
10:39 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
10:48 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
10:24 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
10:19 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:16 PM
NeuroOne Medical Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
05/14/2024
3:10 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
7:57 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
8:06 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:49 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
9:09 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
9:21 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
8:53 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
10:52 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
10:45 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
10:34 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
8:20 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
1:01 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
1:10 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
12:50 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:57 AM
McClurg Ronald W. (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
10:08 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:44 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:14 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
12:51 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
12:29 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
12:41 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:09 PM
NeuroOne Medical Technologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/29/2024
8:00 AM
NeuroOne Medical Technologies (Filer)
Form DEF 14A
01/29/2024
8:02 AM
NeuroOne Medical Technologies (Filer)
Form ARS
01/11/2024
12:04 PM
LYTTON LAURENCE W (Filed by)
NeuroOne Medical Technologies (Subject)
Form SC 13G
01/05/2024
3:16 PM
NeuroOne Medical Technologies (Filer)
Form 424B5
01/03/2024
12:29 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
12:29 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
12:30 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
5:08 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
3:08 PM
NeuroOne Medical Technologies (Issuer)
Volker Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
8:35 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NMTC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners